LOKIASV2_0630_ESMFold_hypothetical_protein	AF-A0A7C8YHZ8-F1-model_v4	AF-A0A7C8YHZ8-F1-model_v4 Uncharacterized protein	6.133E+00	0.082	29	1	144	146	26	171	342	152	0.986	0.427
LOKIASV2_0630_ESMFold_hypothetical_protein	AF-Q64143-F1-model_v4	AF-Q64143-F1-model_v4 Phosphatidylinositol 3-kinase regulatory subunit gamma	4.976E+00	0.069	27	29	146	146	169	287	461	121	0.808	0.258
LOKIASV2_0630_ESMFold_hypothetical_protein	AF-Q63789-F1-model_v4	AF-Q63789-F1-model_v4 Phosphatidylinositol 3-kinase regulatory subunit gamma	5.626E+00	0.063	26	29	146	146	169	287	461	121	0.808	0.258
LOKIASV2_0630_ESMFold_hypothetical_protein	AF-Q5R685-F1-model_v4	AF-Q5R685-F1-model_v4 Phosphatidylinositol 3-kinase regulatory subunit alpha	5.626E+00	0.063	26	29	145	146	437	554	724	120	0.801	0.163
LOKIASV2_0630_ESMFold_hypothetical_protein	AF-P26450-F1-model_v4	AF-P26450-F1-model_v4 Phosphatidylinositol 3-kinase regulatory subunit alpha	5.982E+00	0.063	26	29	145	146	437	554	724	120	0.801	0.163
LOKIASV2_0630_ESMFold_hypothetical_protein	AF-P27986-F1-model_v4	AF-P27986-F1-model_v4 Phosphatidylinositol 3-kinase regulatory subunit alpha	5.626E+00	0.063	26	29	145	146	437	554	724	120	0.801	0.163
LOKIASV2_0630_ESMFold_hypothetical_protein	AF-Q63787-F1-model_v4	AF-Q63787-F1-model_v4 Phosphatidylinositol 3-kinase regulatory subunit alpha	8.130E+00	0.051	24	29	145	146	437	554	724	120	0.801	0.163
LOKIASV2_0630_ESMFold_hypothetical_protein	AF-P23727-F1-model_v4	AF-P23727-F1-model_v4 Phosphatidylinositol 3-kinase regulatory subunit alpha	9.192E+00	0.045	23	29	145	146	437	554	724	120	0.801	0.163
LOKIASV2_0630_ESMFold_hypothetical_protein	6bz3A00	6bz3A00	4.292E+00	0.051	24	7	145	146	2	122	125	139	0.952	0.968
LOKIASV2_0630_ESMFold_hypothetical_protein	4zopB02	4zopB02	4.292E+00	0.051	24	33	145	146	2	115	151	116	0.774	0.755
LOKIASV2_0630_ESMFold_hypothetical_protein	3hhmB02	3hhmB02	5.834E+00	0.045	23	44	145	146	4	105	130	104	0.699	0.785
LOKIASV2_0630_ESMFold_hypothetical_protein	af_Q92569_164_332_1.10.287.1490	af_Q92569_164_332_1.10.287.1490	5.160E+00	0.045	23	31	146	146	8	124	169	119	0.795	0.692
LOKIASV2_0630_ESMFold_hypothetical_protein	4wafB02	4wafB02	5.834E+00	0.040	22	33	145	146	2	115	152	116	0.774	0.750
LOKIASV2_0630_ESMFold_hypothetical_protein	af_A0A2R8QIU7_430_598_1.10.287.1490	af_A0A2R8QIU7_430_598_1.10.287.1490	5.834E+00	0.040	22	29	146	146	6	124	169	122	0.808	0.704
LOKIASV2_0630_ESMFold_hypothetical_protein	2w5jL01	2w5jL01	8.964E+00	0.029	20	33	103	146	8	76	77	73	0.486	0.896
LOKIASV2_0630_ESMFold_hypothetical_protein	af_O43299_320_437_1.25.10.10	af_O43299_320_437_1.25.10.10	4.853E+00	0.024	19	34	139	146	6	117	118	116	0.726	0.949
LOKIASV2_0630_ESMFold_hypothetical_protein	af_K7LE00_78_403_1.20.1560.10	af_K7LE00_78_403_1.20.1560.10	8.964E+00	0.024	19	43	141	146	159	245	326	99	0.678	0.267
LOKIASV2_0630_ESMFold_hypothetical_protein	4zop-assembly1.cif.gz_B	4zop-assembly1.cif.gz_B Co-crystal Structure of Lipid Kinase PI3K alpha with a selective phosphatidylinositol-3 kinase alpha inhibitor	2.944E+00	0.076	28	28	145	146	87	204	240	121	0.808	0.492
LOKIASV2_0630_ESMFold_hypothetical_protein	8tdu-assembly1.cif.gz_B	8tdu-assembly1.cif.gz_B STX-478, a Mutant-Selective, Allosteric Inhibitor bound to PI3Kalpha	4.002E+00	0.063	26	29	145	146	78	195	227	120	0.801	0.520
LOKIASV2_0630_ESMFold_hypothetical_protein	4waf-assembly1.cif.gz_B	4waf-assembly1.cif.gz_B Crystal Structure of a novel tetrahydropyrazolo[1,5-a]pyrazine in an engineered PI3K alpha	4.255E+00	0.057	25	28	145	146	96	213	250	121	0.808	0.472
LOKIASV2_0630_ESMFold_hypothetical_protein	4ayx-assembly1.cif.gz_A	4ayx-assembly1.cif.gz_A STRUCTURE OF THE HUMAN MITOCHONDRIAL ABC TRANSPORTER, ABCB10 (ROD FORM B)	4.524E+00	0.057	25	35	139	146	143	246	571	106	0.719	0.182
LOKIASV2_0630_ESMFold_hypothetical_protein	3hhm-assembly1.cif.gz_B	3hhm-assembly1.cif.gz_B Crystal structure of p110alpha H1047R mutant in complex with niSH2 of p85alpha and the drug wortmannin	6.149E+00	0.040	22	26	145	146	106	222	247	125	0.822	0.474
LOKIASV2_0630_ESMFold_hypothetical_protein	3rqe-assembly1.cif.gz_D	3rqe-assembly1.cif.gz_D Cerebral cavernous malformation 3 (CCM3) in complex with paxillin LD1	4.524E+00	0.034	21	28	139	146	1	129	187	134	0.767	0.690
LOKIASV2_0630_ESMFold_hypothetical_protein	4mu6-assembly1.cif.gz_A	4mu6-assembly1.cif.gz_A Crystal Structure of the N-terminal domain of Effector Protein LegC3 from Legionella pneumophila	8.886E+00	0.024	19	33	145	146	55	165	274	118	0.774	0.405
LOKIASV2_0630_ESMFold_hypothetical_protein	6r1j-assembly1.cif.gz_D-2	6r1j-assembly1.cif.gz_D-2 Structure of the soluble AhlC triple head mutant of the tripartite alpha-pore forming toxin, AHL, from Aeromonas hydrophila.	9.448E+00	0.020	18	15	144	146	57	192	251	139	0.890	0.542
LOKIASV2_0630_ESMFold_hypothetical_protein	ProtVar_P09564_P27986-4_B	ProtVar_P09564_P27986-4_B 	2.065E+00	0.069	27	24	145	146	432	554	732	125	0.836	0.168
LOKIASV2_0630_ESMFold_hypothetical_protein	Q6XM66_unrelaxed_rank_001_alphafold2_ptm_model_3_seed_000.pdb	Q6XM66_unrelaxed_rank_001_alphafold2_ptm_model_3_seed_000.pdb	6.993E+00	0.045	23	30	144	146	1	134	144	134	0.788	0.931
LOKIASV2_0630_ESMFold_hypothetical_protein	A0A6J5N7N5_unrelaxed_rank_001_alphafold2_ptm_model_1_seed_000.pdb	A0A6J5N7N5_unrelaxed_rank_001_alphafold2_ptm_model_1_seed_000.pdb	5.471E+00	0.045	23	34	145	146	452	573	884	122	0.767	0.138
LOKIASV2_0630_ESMFold_hypothetical_protein	A0A516L040_unrelaxed_rank_001_alphafold2_ptm_model_2_seed_000.pdb	A0A516L040_unrelaxed_rank_001_alphafold2_ptm_model_2_seed_000.pdb	7.907E+00	0.024	19	32	145	146	16	155	212	145	0.781	0.660
LOKIASV2_0630_ESMFold_hypothetical_protein	A0A2S0S4Q3_unrelaxed_rank_001_alphafold2_ptm_model_1_seed_000.pdb	A0A2S0S4Q3_unrelaxed_rank_001_alphafold2_ptm_model_1_seed_000.pdb	8.939E+00	0.020	18	8	146	146	148	304	304	159	0.952	0.516
LOKIASV2_0630_ESMFold_hypothetical_protein	A0A3G1RP79_2_unrelaxed_rank_001_alphafold2_ptm_model_3_seed_000.pdb	A0A3G1RP79_2_unrelaxed_rank_001_alphafold2_ptm_model_3_seed_000.pdb	7.436E+00	0.011	15	26	138	146	28	139	1106	125	0.774	0.101
